Key Executives
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Dr. Carl L.G. Hansen Ph.D. | CEO, President & Chairperson | 694.32k | -- | 1975 |
| Mr. Andrew Booth M.B.A. | Chief Financial Officer | 655.1k | -- | 1974 |
| Dr. Veronique Lecault Ph.D. | COO & Director | 631.82k | 1.37M | 1985 |
| Mr. Tryn T. Stimart Esq., J.D., M.Sc. | Chief Legal Officer, CCO, Compliance Officer, Corporate Secretary & Privacy Officer | 648.43k | -- | 1970 |
| Marcie Thiessen CPA, CGA | Senior Director of Finance & Accounting | -- | -- | -- |
| Dr. Ester Falconer Ph.D. | Chief Technology Officer | -- | -- | 1975 |
AbCellera Biologics Inc.
- Sector:
- Healthcare
- Industry: Biotechnology
- Full Time Employees:
- 586
Description
AbCellera Biologics Inc. builds an engine for antibody drug discovery and development. Its engine discovers antibodies from natural immune responses, which are pre-enriched for antibodies. The company's preclinical products are ABCL635 for metabolic and endocrine conditions; and ABCL575 for atopic dermatitis. It has a research collaboration and license agreement with Eli Lilly and Company; a research collaboration with Confo Therapeutics for the discovery of therapeutic antibody candidates targeting two undisclosed GPCR targets; and strategic collaboration with Biogen Inc. to discover therapeutic antibodies for neurological conditions, as well as collaboration with Viking Global Investors and ArrowMark Partners. The company was incorporated in 2012 and is headquartered in Vancouver, Canada.
Corporate Governance
Upcoming Events
February 18, 2025 at 10:59 AM UTC - February 24, 2025 at 12:00 PM UTC
AbCellera Biologics Inc. Earnings Date
Recent Events
Recent Events Information Not Available